V

Vivasc Therapeutics

10 employees

Vivasc Therapeutics is a drug development company that specializes in proprietary cardiac targeting peptide platform technology.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Afib
Health Care
Medical
Pharmaceutical
Drug Development
Cardiology
Atrial Fibrillation

Date founded

2019

Funding rounds raised

Total raised

$284K

from 1 investors over 1 rounds

V

Vivasc Therapeutics raised $284K on October 19, 2022

Investors: National Heart, Lung, and Blood Institute

FAQ